ArticleThe oncologist2023

Predicting Hyperglycemia Among Patients Receiving Alpelisib Plus Fulvestrant for Metastatic Breast Cancer.

Xuan Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.